Related Experiment Videos
Vasopressin effective in reversing catecholamine-resistant vasodilatory shock
1Department of Anaesthesia and Surgical Intensive Care, Changi General Hospital, Singapore.
Anaesthesia and Intensive Care
|June 15, 2000
Summary
A patient with perforated appendicitis experienced severe vasodilatory shock and heart attack. Vasopressin, used as a last resort, successfully reversed the refractory shock, suggesting its value in critical care.
Area of Science:
- Critical Care Medicine
- Cardiovascular Physiology
- Sepsis Pathophysiology
Background:
- Perforated appendicitis can lead to severe vasodilatory shock.
- Perioperative acute myocardial infarction presents a significant challenge in managing septic shock.
- Refractory vasodilatory shock requires novel therapeutic approaches.
Observation:
- A patient with perforated appendicitis developed progressive vasodilatory shock.
- The patient experienced a perioperative acute myocardial infarction.
- Initial cardiovascular support with dopamine, noradrenaline, and dobutamine was insufficient.
Findings:
- Intra-aortic balloon counterpulsation was initiated for hemodynamic support.
- Vasopressin was introduced as a rescue therapy for catecholamine-resistant shock.
- The introduction of vasopressin was associated with patient recovery.
Implications:
- Vasopressin may serve as a crucial adjunct therapy for refractory vasodilatory shock.
- This case highlights the potential role of vasopressin in complex septic shock scenarios.
- Further research is warranted to confirm the efficacy of vasopressin in catecholamine-resistant shock.